, Singapore

GIC joins $140m investment pool for DNA analysis firm

The company develops a portable DNA/RNA sequencer for customers in 70 countries.

GIC, Singapore's sovereign wealth fund, has invested in the fundraising by DNA/RNA sequencer developer Oxford Nanopore Technologies (ONT). ONT announced that it raised a total of US$140m from other global investors.

GIC did not specify how much it invested in the firm.

According to an announcement, ONT is the developer of the world’s only portable, scalable, real-time DNA/RNA sequencer, with a customer base spanning over 70 countries. Other key investors include China Construction Bank International (CCBI), HostPlus and existing investors.

“The funds raised will be used to support a new manufacturing facility, commercial expansion and the development of new innovative products,” GIC said.

Bryan Yeo, chief investment officer of public equities at GIC, said “Oxford Nanopore has a unique business model of providing accessible, real-time DNA analysis technologies that can be applied to pocket-sized or industrial installations. We believe this will continue to drive growth in their user base as well as in new applications for DNA or RNA sequencing. This investment reflects our confidence in the global demand outlook for DNA information across many industries over the long term.” 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Tuas pharmaceutical facility put up for sale at $90m
The nine-hectare site has about 535,000 sq ft of untapped gross floor area for potential expansion.
Brand New Land launches four freehold terrace homes in District 11
Prices at the Solstice development start from $9.38m, with completion targeted for the second half of 2027.